Stage I-IIIA - Invasive

Insurance Coverage & Financial Assistance

Genomic Health believes that everyone should have access to the information they need to make confident, informed decisions about their cancer treatments. That’s why Genomic Health created the Genomic Access Program (GAP), which helps eligible patients navigate insurance and other payment options for Oncotype DX Breast Recurrence Score tests. Contact Customer Service by phone 866-ONCOTYPE (866-662-6897) or by email at customerservice@genomichealth.com.

Insurance coverage

Medicare and the majority of private insurance carriers cover the Oncotype DX Breast Recurrence Score test for eligible patients with early-stage invasive breast cancer. Since insurance coverage can vary across the country, it’s a good idea to check with your carrier.

Additionally, we assist you through the claims process with your insurance company, including with your permission, help with appeals for any denial of coverage.

If your insurance covers the test, our patient assistance program will:

  • Work with your physician to get prior authorization from your insurance company (if required).
  • Bill insurance companies directly when possible.
  • Process the claim once the test is complete.
  • Assist in the appeal process if a claim is denied.

To get started with GAP, contact Customer Service at 866-ONCOTYPE (866-662-6897).

Financial assistance

Genomic Health offers financial assistance programs for eligible patients with financial hardship. These programs are based on financial eligibility. Contact Customer Service by phone at 866-ONCOTYPE (866-662-6897) or via email at customerservice@genomichealth.com.

Contact Us

Real Patients. Real Stories.

 

Stay in Touch

Have a specific question? Want to keep up with our latest news? We're here for you.

Contact Us
Making cancer care smarter.™